Detailed information of E2F8

  1. Home
  2. TF > E2F8

Dataset summary

TF Name: E2F8 Species: Homo sapiens
Cell-type/Tissue: GM12878 (female B-cells lymphoblastoid cell line) Condition/Source:
JASPAR ID: MA0865.1 Collections: Permissive
References: ENCODE ENCSR793HVL GTRD EXP040299

External links

Models for profile: MA0865.1

Download TFBSs (hg38)

Download TFBSs in BED and FASTA format

Download trained model

Download trained prediction models

Visualize TFBSs in UCSC

Send TFBSs BED file to UCSC genome browser

Summary plots

Statistical details

Model Peak caller Model ID Enrichment Zone TFBSs Score threshold Centrality p-value (log10)
DAMO MACS MA0865.1 0.5 249 85.5 0.0

32 datasets found for the same TF (E2F8) in other cell-types/tissues

TF Name Cell-line Condition/Source Collections Species Identifiers JASPAR ID
E2F8 HS-SY-2(Monophasic synovial sarcoma) Gemotype: HS-SY-II parental line untagged Treatment: no shRNA Permissive Homo sapiens GSE108926 ... MA0865.1
E2F8 MOLM-13(acute monocytic leukemia(AML), Homo sapiens) Treatment: stable cell line was infected with FLAG-ZFP64 lentivirus Permissive Homo sapiens GSE115236 ... MA0865.1
E2F8 MOLM-13(acute monocytic leukemia(AML), Homo sapiens) Treatment: stable cell line was infected with FLAG-ZFP64 lentivirus Permissive Homo sapiens GSE115236 ... MA0865.1
E2F8 NOMO-1 (acute monocytic leukemia) Treatment: stable cell line was infected with FLAG-ZFP64 lentivirus Permissive Homo sapiens GSE115236 ... MA0865.1
E2F8 NOMO-1 (acute monocytic leukemia) Treatment: stable cell line was infected with FLAG-ZFP64 lentivirus Permissive Homo sapiens GSE115236 ... MA0865.1
E2F8 HKC8 (kidney proximal tubule cell line) Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours, HIF1a knockout Permissive Homo sapiens GSE120885 ... MA0865.1
E2F8 HKC8 (kidney proximal tubule cell line) Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours, HIF2a knockout Permissive Homo sapiens GSE120885 ... MA0865.1
E2F8 HKC8 (kidney proximal tubule cell line) Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours, HIF1a knockout Permissive Homo sapiens GSE120885 ... MA0865.1
E2F8 HKC8 (kidney proximal tubule cell line) Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours, HIF2a knockout Permissive Homo sapiens GSE120885 ... MA0865.1
E2F8 RCC4 (kidney cancer cell line) Treatment: degree of hypoxia - normoxia Permissive Homo sapiens GSE120885 ... MA0865.1
E2F8 RCC4 (kidney cancer cell line) Treatment: degree of hypoxia - normoxia Permissive Homo sapiens GSE120885 ... MA0865.1
E2F8 HepG2 (hepatoblastoma) Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours Permissive Homo sapiens GSE120885 ... MA0865.1
E2F8 HepG2 (hepatoblastoma) Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours Permissive Homo sapiens GSE120885 ... MA0865.1
E2F8 HKC8 (kidney proximal tubule cell line) Treatment: degree of hypoxia 0.5%, duration of hypoxia 6 hours Permissive Homo sapiens GSE120885 ... MA0865.1
E2F8 HKC8 (kidney proximal tubule cell line) Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours Permissive Homo sapiens GSE120885 ... MA0865.1
E2F8 HKC8 (kidney proximal tubule cell line) Treatment: degree of hypoxia 0.5%, duration of hypoxia 48 hours Permissive Homo sapiens GSE120885 ... MA0865.1
E2F8 HKC8 (kidney proximal tubule cell line) Treatment: degree of hypoxia 3.0%, duration of hypoxia 6 hours Permissive Homo sapiens GSE120885 ... MA0865.1
E2F8 HKC8 (kidney proximal tubule cell line) Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours Permissive Homo sapiens GSE120885 ... MA0865.1
E2F8 U937 (adult acute monocytic leukemia) Treatment: shRNA Genotype: shCHAF1B knockout Permissive Homo sapiens GSE120063 ... MA0865.1
E2F8 CD20+ B-cells Treatment: None; Permissive Homo sapiens GSE29611 ... MA0865.1
E2F8 Hs68 (Canavan disease) Tissue: normal breast; Treatment: infected with packaged LKO lentivirus vector containg CBX7shRNA; Permissive Homo sapiens GSE40740 ... MA0865.1
E2F8 HeLa (cervical adenocarcinoma) Source: micrococcal nuclease-digested chromatin; Permissive Homo sapiens GSE57149 ... MA0865.1
E2F8 MCF7 (Invasive ductal breast carcinoma) Genotype: NELF-E knockdown; Treatment: vehicle, flagNELF-Ewildtype; Permissive Homo sapiens GSE74141 ... MA0865.1
E2F8 MCF7 (Invasive ductal breast carcinoma) Genotype: NELF-E knockdown; Treatment: vehicle, flagNELF-Ewildtype; Permissive Homo sapiens GSE74141 ... MA0865.1
E2F8 MCF7 (Invasive ductal breast carcinoma) Genotype: NELF-E knockdown; Treatment: vehicle, flagNELF-Emutant; Permissive Homo sapiens GSE74141 ... MA0865.1
E2F8 MCF7 (Invasive ductal breast carcinoma) Genotype: NELF-E knockdown; Treatment: vehicle, flagNELF-Emutant; Permissive Homo sapiens GSE74141 ... MA0865.1
E2F8 MOLM-13(acute monocytic leukemia(AML), Homo sapiens) Treatment: Control; Permissive Homo sapiens GSE80779 ... MA0865.1
E2F8 HeLa (cervical adenocarcinoma) Developmental stage: S/G2; Permissive Homo sapiens GSE111381 ... MA0865.1
E2F8 K562 (myelogenous leukemia) Permissive Homo sapiens ENCSR953DVM MA0865.1
E2F8 MCF7 (Invasive ductal breast carcinoma) Permissive Robust Homo sapiens ENCSR897ZXU MA0865.1
E2F8 BJ (fibroblasts) Permissive Homo sapiens GSE90454 ... MA0865.1
E2F8 A549 (lung carcinoma) Permissive Homo sapiens GSE90454 ... MA0865.1